# Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma

> **NCT01380106** · PHASE2 · COMPLETED · sponsor: **Boston VA Research Institute, Inc.** · enrollment: 33 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Lenalidomide 15mg
- **DRUG:** Lenalidomide 25mg

## Key facts

- **NCT ID:** NCT01380106
- **Lead sponsor:** Boston VA Research Institute, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2017-09-11
- **Final completion:** 2017-09-11
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2021-01-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01380106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01380106, "Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01380106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*